PARKER LABORATORIES, INC. FDA Inspection Record

FEI 2212018 · Inspections, Form 483s, warning letters and import refusals

PARKER LABORATORIES, INC. is an FDA-registered facility (FEI 2212018) located in FAIRFIELD, NJ, US. RegDataLab tracks 6 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Jun 14, 2023: Voluntary Action Indicated (VAI)
Inspections on record
6 (5 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
5, latest Mar 22, 2024
Import refusals
4

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 14, 2023Voluntary Action Indicated (VAI)Absence of Written Procedures (21 CFR 211.100(a))
Lack of written stability program (21 CFR 211.166(a))
Reports of Analysis (Components) (21 CFR 211.84(d)(2))
Actual yield, % of theoretical yield (21 CFR 211.188(b)(7))
and 1 more
May 23, 2023Voluntary Action Indicated (VAI)Lack/Inad procedure-Monitoring/Control of Validated Proces (21 CFR 820.75(b))
Product rework documentation, DHR {see also 820.184} (21 CFR 820.90(b)(2))
Production and Process Change Procedures, lack of or Inad. (21 CFR 820.70(b))
Lack of or inadequate process validation (21 CFR 820.75(a))
Mar 20, 2018Voluntary Action Indicated (VAI)Training - Lack of or inadequate procedures (21 CFR 820.25(b))
Lack of or inadequate procedures (21 CFR 820.100(a))
Report of violation of the Act (see 803.52(e)(9)) (21 CFR 806.10(a)(2))
Oct 15, 2014Voluntary Action Indicated (VAI)Environmental control Lack of or inadequate procedures (21 CFR 820.70(c))
Lack of or inadequate process validation (21 CFR 820.75(a))
May 19, 2011No Action Indicated (NAI)No citations listed
Feb 19, 2009Voluntary Action Indicated (VAI)Lack of or inadequate In-process acceptance procedures (21 CFR 820.80(c))
Specified requirements (21 CFR 820.70(g))
Report of Death or Serious Injury (21 CFR 803.50(a)(1))

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 22, 2024Class IIZ-1604-2024Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.
Product demonstrates low viscosity.
Jan 22, 2024Class IIZ-1204-2024Tensive Conductive Adhesive Gel, Product Ref. 22-60. 12, 1 case contains 12 inner boxes…
Five complaints were received related to viscosity of Tensive Conductive Adhesive Gel Ref 22-60.
Aug 2, 2023Class IID-1089-2023Protex Foaming Hand Sanitizer (Benzalkonium Chloride 0.13%), packaged in a) 2 fl oz/60 mL… and 4 more products
CGMP Deviations
Apr 13, 2017Class IIZ-1777-2018Sterile Aquasonic 100 Ultrasound Transmission Gel, 20 grams, Model Number 01-01-4, 400…
There is a potential for the gel packets to have leaks in the packet seal.
Aug 6, 2014Class IIZ-0145-2015Parker Eclipse Probe Cover, Latex Free, REF 38-01, 10 Eclipse Probe Covers, Size…
Parker Laboratories, Inc. received a report of an incorrect expiration date on the inner boxes and on the plastic bags of the Eclipse Probe…

FDA record score

17 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

10 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJun 14, 20236 x 0.63.6
Inspection classified VAIMay 23, 20236 x 0.63.6
Class II recall Z-1604-2024, this FEI as the recalling firmMar 22, 20244 x 0.62.4
Class II recall Z-1204-2024, this FEI as the recalling firmJan 22, 20244 x 0.62.4
Class II recall D-1089-2023, this FEI as the recalling firmAug 2, 20234 x 0.62.4
Inspection classified VAIMar 20, 20186 x 0.251.5
Class II recall Z-1777-2018, this FEI as the recalling firmApr 13, 20174 x 0.251
Inspection classified VAIOct 15, 201410 years or older, so it adds no points0
Class II recall Z-0145-2015, this FEI as the recalling firmAug 6, 201410 years or older, so it adds no points0
Inspection classified VAIFeb 19, 200910 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing PARKER LABORATORIES, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check PARKER LABORATORIES, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Parker Laboratories, Inc.
Location
FAIRFIELD, NJ (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.